Literature DB >> 8946809

Glutamic acid decarboxylase--gene to antigen to disease.

A Lernmark1.   

Abstract

Glutamic acid decarboxylase (GAD) enzymes catalyse the formation of gamma-aminobuturic acid (GABA), which is a major transmitter in the central nervous system but also exerts functions in peripheral organs. Recent-molecular analyses have revealed surprising new roles for the GAD isoforms in human diseases of autoimmune character including neurological disorders and insulin-dependent diabetes. In the 1995 Frontiers in Medicine Symposium, the co-authors of this review discussed the genetics, cell biology, molecular immunology and the role of GAD as autoantigens in human autoimmunity. Studies on disease diagnosis, prediction, and prognosis have revealed unique patterns of reactivities in both cellular and humoral immune responses. Further work will be needed to establish whether the GAD molecules can be used to treat autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8946809     DOI: 10.1046/j.1365-2796.1996.27859000.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  17 in total

1.  LAMP-2-deficient human B cells exhibit altered MHC class II presentation of exogenous antigens.

Authors:  Victoria L Crotzer; Nicole Glosson; Delu Zhou; Ichizo Nishino; Janice S Blum
Journal:  Immunology       Date:  2010-11       Impact factor: 7.397

2.  HSP90alpha and HSP90beta isoforms selectively modulate MHC class II antigen presentation in B cells.

Authors:  Josetta L Houlihan; Jennifer J Metzler; Janice S Blum
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

3.  Insulinoma-released exosomes or microparticles are immunostimulatory and can activate autoreactive T cells spontaneously developed in nonobese diabetic mice.

Authors:  Huiming Sheng; Saleema Hassanali; Courtney Nugent; Li Wen; Emma Hamilton-Williams; Peter Dias; Yang D Dai
Journal:  J Immunol       Date:  2011-07-06       Impact factor: 5.422

4.  An AP-3-dependent mechanism drives synaptic-like microvesicle biogenesis in pancreatic islet beta-cells.

Authors:  Arthur T Suckow; Branch Craige; Victor Faundez; William J Cain; Steven D Chessler
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-05-04       Impact factor: 4.310

5.  Novel microglomerular structures in the olfactory bulb of mice.

Authors:  Brian W Lipscomb; Helen B Treloar; Charles A Greer
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

6.  Identification and modulation of a naturally processed T cell epitope from the diabetes-associated autoantigen human glutamic acid decarboxylase 65 (hGAD65).

Authors:  G T Nepom; J D Lippolis; F M White; S Masewicz; J A Marto; A Herman; C J Luckey; B Falk; J Shabanowitz; D F Hunt; V H Engelhard; B S Nepom
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

7.  Role of the proteasome in excitotoxicity-induced cleavage of glutamic acid decarboxylase in cultured hippocampal neurons.

Authors:  Márcio S Baptista; Carlos V Melo; Mário Armelão; Dennis Herrmann; Diogo O Pimentel; Graciano Leal; Margarida V Caldeira; Ben A Bahr; Mário Bengtson; Ramiro D Almeida; Carlos B Duarte
Journal:  PLoS One       Date:  2010-04-12       Impact factor: 3.240

8.  Modulation of antigen presentation by autoreactive B cell clones specific for GAD65 from a type I diabetic patient.

Authors:  J P Banga; J K Moore; N Duhindan; A M Madec; P M van Endert; J Orgiazzi; J Endl
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

9.  Cerebellar ataxia associated with anti-glutamic acid decarboxylase autoantibodies.

Authors:  M Vianello; B Tavolato; M Armani; B Giometto
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

10.  An analysis of the cross-reactivity of autoantibodies to GAD65 and GAD67 in diabetes.

Authors:  Bindu Jayakrishnan; David E Hoke; Christopher G Langendorf; Ashley M Buckle; Merrill J Rowley
Journal:  PLoS One       Date:  2011-04-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.